


Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications

DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics

Landkind launches LK-01 Pure Salidroside for cognitive and athletic performance

Double Rainbow launches Landkind to deliver a new class of sustainable wellness products

Double Rainbow announces $10 million investment from Betta Pharmaceuticals
